Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lung Metastases × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 233 Neoplasms 173 Prostatic Neoplasms 102 Polycystic Ovary Syndrome 101 Colorectal Neoplasms 96 Carcinoma, Hepatocellular 90 Carcinoma, Non-Small-Cell Lung 77 Lung Neoplasms 60 Stomach Neoplasms 55 Precursor Cell Lymphoblastic Leukemia-Lymphoma 54 Pain 53 Neoplasm Metastasis 47 Multiple Myeloma 44 Pancreatic Neoplasms 43 Keratosis, Actinic 40 Pain, Postoperative 39 Leukemia, Myeloid, Acute 37 Head and Neck Neoplasms 36 Leiomyoma 35 Liver Neoplasms 34 Recurrence 33 Lymphoma 33 Colonic Neoplasms 32 Uterine Cervical Neoplasms 31 Papillomavirus Infections 30 Brain Neoplasms 30 Infertility 29 Lymphoma, Follicular 28 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 28 Leukemia 28

Interventions

Zoledronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03932071 2019-05-06

Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Unknown

Lung Metastases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡